UCM-1306   Click here for help

GtoPdb Ligand ID: 12170

Synonyms: compound 26 [PMID: 36044544] | UCM1306
Compound class: Synthetic organic
Comment: UCM-1306 is a positive allosteric modulator (PAM) of the human dopamine D1 receptor [1]. It increases the affinity of the receptor for dopamine (i.e. the orthosteric agonist), increases the maximal effect of dopamine but is inactive in the absence of dopamine. UCM-1306, which is orally bioavailable, is being investigated as a mechanism to improve the therapeutic effect of L-DOPA in the treatment of Parkinson's disease
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 2
Hydrogen bond donors 1
Rotatable bonds 4
Topological polar surface area 58.53
Molecular weight 279.07
XLogP 4.24
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES FCOc1ccccc1c1ccc(cc1)S(=O)(=N)C
Isomeric SMILES N=S(=O)(c1ccc(c2ccccc2OCF)cc1)C
InChI InChI=1S/C14H14FNO2S/c1-19(16,17)12-8-6-11(7-9-12)13-4-2-3-5-14(13)18-10-15/h2-9,16H,10H2,1H3
InChI Key VCSBOASGFYJGGT-UHFFFAOYSA-N
References
1. García-Cárceles J, Vázquez-Villa H, Brea J, Ladron de Guevara-Miranda D, Cincilla G, Sánchez-Martínez M, Sánchez-Merino A, Algar S, Teresa de Los Frailes M, Roberts RS et al.. (2022)
2-(Fluoromethoxy)-4'-(S-methanesulfonimidoyl)-1,1'-biphenyl (UCM-1306), an Orally Bioavailable Positive Allosteric Modulator of the Human Dopamine D1 Receptor for Parkinson's Disease.
J Med Chem, 65 (18): 12256-12272. [PMID:36044544]